Header Logo

Connection

BIYKEM BOZKURT to Humans

Back to Details
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Humans.
BIYKEM BOZKURT
Connection Strength
2.102
Humans
  1. Albuminuria as a diagnostic criterion and a therapeutic target in heart failure and other cardiovascular disease. Eur J Heart Fail. 2025 Nov; 27(11):2357-2371.
    View in: PubMed
    Score: 0.025
  2. Cardiac rhythm devices in heart failure with reduced ejection fraction?-?role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document. Eur J Heart Fail. 2025 Jul; 27(7):1242-1261.
    View in: PubMed
    Score: 0.024
  3. Compensation Models in?Heart?Failure: Navigating the Complexities for Optimal?Outcomes. JACC Heart Fail. 2024 Aug; 12(8):1500-1504.
    View in: PubMed
    Score: 0.023
  4. Treatment of Obesity in Heart?Failure: The New Era in the Aftermath of the STEP-HFpEF and SELECT Trials. JACC Heart Fail. 2024 Jul; 12(7):1309-1313.
    View in: PubMed
    Score: 0.023
  5. The Year in Review in Heart?Failure. JACC Heart Fail. 2024 Jun; 12(6):1128-1133.
    View in: PubMed
    Score: 0.023
  6. Pre-Heart?Failure, Heart Stress, and Subclinical Heart?Failure: Bridging Heart Health and Heart?Failure. JACC Heart Fail. 2024 Jun; 12(6):1115-1118.
    View in: PubMed
    Score: 0.023
  7. Concerning Trends of Rising Heart?Failure Mortality Rates. JACC Heart Fail. 2024 May; 12(5):970-972.
    View in: PubMed
    Score: 0.023
  8. Contemporary pharmacological treatment and management of heart failure. Nat Rev Cardiol. 2024 08; 21(8):545-555.
    View in: PubMed
    Score: 0.023
  9. Need to Define Severe Heart?Failure: A Subgroup of Stage C Heart?Failure. JACC Heart Fail. 2024 Mar; 12(3):595-598.
    View in: PubMed
    Score: 0.023
  10. Treatment of Clusters of Risks to Prevent Heart?Failure. JACC Heart Fail. 2024 02; 12(2):417-420.
    View in: PubMed
    Score: 0.022
  11. Heart?Failure in Women: Special Issue of JACC: Heart?Failure. JACC Heart Fail. 2023 12; 11(12):1767-1768.
    View in: PubMed
    Score: 0.022
  12. Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America. J Card Fail. 2023 10; 29(10):1412-1451.
    View in: PubMed
    Score: 0.022
  13. Heart?Failure in Women: Special Issue in JACC: Heart?Failure. JACC Heart Fail. 2023 09; 11(9):1287.
    View in: PubMed
    Score: 0.022
  14. Pre-Heart?Failure: An Important Opportunity to Prevent a?Deadly?Disease. JACC Heart Fail. 2023 08; 11(8 Pt 1):1027-1031.
    View in: PubMed
    Score: 0.022
  15. Technology and Heart?Failure Therapeutics (THT) Special Issue in JACC: Heart?Failure. JACC Heart Fail. 2023 08; 11(8 Pt 2):1037-1038.
    View in: PubMed
    Score: 0.022
  16. Differentiation Between Worsening Heart?Failure and Decompensated Heart?Failure. JACC Heart Fail. 2023 07; 11(7):859-861.
    View in: PubMed
    Score: 0.022
  17. Mortality, Outcomes, Costs, and Use of?Medicines Following a First Heart?Failure?Hospitalization: EVOLUTION HF. JACC Heart Fail. 2023 10; 11(10):1320-1332.
    View in: PubMed
    Score: 0.021
  18. Nonresponse to Heart?Failure?Therapy: An Important Trajectory. JACC Heart Fail. 2023 06; 11(6):729-732.
    View in: PubMed
    Score: 0.021
  19. Proposed New Conceptualization for Definition of Decompensated?HF: Taking the Acute Out of Decompensation. JACC Heart Fail. 2023 03; 11(3):368-371.
    View in: PubMed
    Score: 0.021
  20. Shedding Light on Mechanisms of Myocarditis With COVID-19 mRNA Vaccines. Circulation. 2023 03 14; 147(11):877-880.
    View in: PubMed
    Score: 0.021
  21. Treatment of Advanced (Stage D) Heart?Failure in the New Era. JACC Heart Fail. 2023 02; 11(2):258-260.
    View in: PubMed
    Score: 0.021
  22. Successful Decongestion as a Clinical Target, Performance Indicator, and as a Study Endpoint in Hospitalized Heart Failure Patients. JACC Heart Fail. 2023 01; 11(1):126-129.
    View in: PubMed
    Score: 0.021
  23. How to Initiate and Uptitrate GDMT in Heart?Failure: Practical Stepwise Approach to Optimization of GDMT. JACC Heart Fail. 2022 12; 10(12):992-995.
    View in: PubMed
    Score: 0.021
  24. What to and Not to Monitor for Uptitration of GDMT in Patients With Heart?Failure: The Case for Patient Self-Uptitration of GDMT. JACC Heart Fail. 2022 11; 10(11):881-884.
    View in: PubMed
    Score: 0.021
  25. Targets for Success in Treatment of Patients Hospitalized for Heart?Failure. JACC Heart Fail. 2022 10; 10(10):782-784.
    View in: PubMed
    Score: 0.020
  26. Heart?Failure Drug Treatment-Inertia,?Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). JACC Heart Fail. 2023 01; 11(1):1-14.
    View in: PubMed
    Score: 0.020
  27. The Need to Stop Inappropriate Coding for Acute Kidney Injury in Heart Failure. JACC Heart Fail. 2022 09; 10(9):692-694.
    View in: PubMed
    Score: 0.020
  28. It Is Time to Screen for Heart?Failure: Why and How? JACC Heart Fail. 2022 08; 10(8):598-600.
    View in: PubMed
    Score: 0.020
  29. JACC: Heart?Failure: A New Vision With the New Editorial Team. JACC Heart Fail. 2022 07; 10(7):525-526.
    View in: PubMed
    Score: 0.020
  30. 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circ Cardiovasc Qual Outcomes. 2022 07; 15(7):e000111.
    View in: PubMed
    Score: 0.020
  31. Telehealth in Heart Failure. Heart Fail Clin. 2022 Apr; 18(2):213-221.
    View in: PubMed
    Score: 0.020
  32. The Emergence of the Heart Failure and Critical Care Medicine Specialist: An Unmet Need That Needs a Rapid Solution. J Card Fail. 2022 02; 28(2):343-345.
    View in: PubMed
    Score: 0.019
  33. Myocarditis With COVID-19 mRNA Vaccines. Circulation. 2021 08 10; 144(6):471-484.
    View in: PubMed
    Score: 0.019
  34. Cardiac Rehabilitation for Patients With?Heart?Failure: JACC Expert Panel. J Am Coll Cardiol. 2021 03 23; 77(11):1454-1469.
    View in: PubMed
    Score: 0.018
  35. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). Circ Cardiovasc Qual Outcomes. 2021 04; 14(4):e000102.
    View in: PubMed
    Score: 0.018
  36. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail. 2021 03; 23(3):352-380.
    View in: PubMed
    Score: 0.018
  37. Fifth Annual Go Red for Women Issue. Circulation. 2021 02 16; 143(7):613-614.
    View in: PubMed
    Score: 0.018
  38. 2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure). J Am Coll Cardiol. 2021 04 27; 77(16):2053-2150.
    View in: PubMed
    Score: 0.018
  39. Ins and Outs: Perspectives of Inpatient Prescribing for Sacubitril/Valsartan. Ann Pharmacother. 2021 06; 55(6):805-813.
    View in: PubMed
    Score: 0.018
  40. President's Message. J Card Fail. 2020 10; 26(10):905-906.
    View in: PubMed
    Score: 0.018
  41. Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. J Card Fail. 2020 05; 26(5):370.
    View in: PubMed
    Score: 0.017
  42. Fourth Annual Go Red for Women Issue. Circulation. 2020 02 18; 141(7):499-500.
    View in: PubMed
    Score: 0.017
  43. Substance and Substrate: LVEF and Sex Subgroup Analyses of PARAGON-HF and PARADIGM-HF Trials. Circulation. 2020 02 04; 141(5):362-366.
    View in: PubMed
    Score: 0.017
  44. Update in recent clinical trials in heart failure. Curr Opin Cardiol. 2019 07; 34(4):307-314.
    View in: PubMed
    Score: 0.016
  45. Reasons for Lack of Improvement in Treatment With Evidence-Based Therapies in Heart Failure. J Am Coll Cardiol. 2019 05 21; 73(19):2384-2387.
    View in: PubMed
    Score: 0.016
  46. Enkephalins and the Opioid System of the Heart. Circ Heart Fail. 2019 05; 12(5):e005851.
    View in: PubMed
    Score: 0.016
  47. Target Dose Versus Maximum Tolerated Dose in Heart Failure: Time to Calibrate and Define Actionable Goals. JACC Heart Fail. 2019 04; 7(4):359-362.
    View in: PubMed
    Score: 0.016
  48. Third Annual Go Red for Women Issue. Circulation. 2019 02 19; 139(8):999-1000.
    View in: PubMed
    Score: 0.016
  49. WORSENING RENAL FUNCTION IN ACUTE DECOMPENSATED HEART FAILURE: A BAD SIGN, OR MAYBE NOT? Trans Am Clin Climatol Assoc. 2019; 130:41-50.
    View in: PubMed
    Score: 0.016
  50. High-Sensitivity Cardiac Troponin: From Patient Phenotypes to Clinical Events in Patients With Heart Failure With Preserved Ejection Fraction. J Am Heart Assoc. 2018 12 18; 7(24):e011174.
    View in: PubMed
    Score: 0.016
  51. What Is New in Heart Failure Management in 2017? Update on ACC/AHA Heart Failure Guidelines. Curr Cardiol Rep. 2018 04 17; 20(6):39.
    View in: PubMed
    Score: 0.015
  52. Heart Failure in Women. Methodist Debakey Cardiovasc J. 2017 Oct-Dec; 13(4):216-223.
    View in: PubMed
    Score: 0.014
  53. Comparison of Frequency of Cardiovascular Events and Mortality in Patients With Heart Failure Using Versus Not Using Cocaine. Am J Cardiol. 2017 06 15; 119(12):2030-2034.
    View in: PubMed
    Score: 0.014
  54. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. Circulation. 2016 12 06; 134(23):e579-e646.
    View in: PubMed
    Score: 0.014
  55. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016 12 06; 134(23):e535-e578.
    View in: PubMed
    Score: 0.014
  56. Usefulness of the Sum of Pulmonary Capillary Wedge Pressure and Right Atrial Pressure as a Congestion Index that Prognosticates Heart Failure Survival (from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness Trial). Am J Cardiol. 2016 09 15; 118(6):854-859.
    View in: PubMed
    Score: 0.013
  57. Peripartum cardiomyopathy: current state of knowledge, new developments and future directions. Curr Cardiol Rev. 2014 Nov; 10(4):317-26.
    View in: PubMed
    Score: 0.012
  58. Chagas cardiomyopathy is associated with higher incidence of stroke: a meta-analysis of observational studies. J Card Fail. 2014 Dec; 20(12):931-8.
    View in: PubMed
    Score: 0.012
  59. Update: shortness of breath. Circulation. 2014 Apr 15; 129(15):e447-9.
    View in: PubMed
    Score: 0.011
  60. Redefining myocardial infarction: what is new in the ESC/ACCF/AHA/WHF Third Universal Definition of myocardial infarction? Methodist Debakey Cardiovasc J. 2013 Jul-Sep; 9(3):169-72.
    View in: PubMed
    Score: 0.011
  61. The treatment of heart failure in the 21st century: is the glass half empty or half full? Methodist Debakey Cardiovasc J. 2013 Jan-Mar; 9(1):3-5.
    View in: PubMed
    Score: 0.010
  62. Peripartum cardiomyopathy: a contemporary review. Methodist Debakey Cardiovasc J. 2013 Jan-Mar; 9(1):38-43.
    View in: PubMed
    Score: 0.010
  63. Response to Ryan and Parwani: heart failure patients with low blood pressure: how should we manage neurohormonal blocking drugs? Circ Heart Fail. 2012 Nov; 5(6):820-1.
    View in: PubMed
    Score: 0.010
  64. Echocardiographic changes during treatment of acute decompensated heart failure: insights from the ESCAPE trial. J Card Fail. 2012 Oct; 18(10):792-8.
    View in: PubMed
    Score: 0.010
  65. Hyperacute T-waves: Wolff-Parkinson-White pattern or acute coronary syndrome? J Emerg Med. 2013 Feb; 44(2):332-5.
    View in: PubMed
    Score: 0.010
  66. Worsening renal function is not associated with response to treatment in acute heart failure. Int J Cardiol. 2013 Sep 01; 167(5):1912-7.
    View in: PubMed
    Score: 0.010
  67. Delayed recovery in peripartum cardiomyopathy: an indication for long-term follow-up and sustained therapy. Eur J Heart Fail. 2012 Aug; 14(8):895-901.
    View in: PubMed
    Score: 0.010
  68. New insights into mechanisms of action of carvedilol treatment in chronic heart failure patients--a matter of time for contractility. J Card Fail. 2012 Mar; 18(3):183-93.
    View in: PubMed
    Score: 0.010
  69. Recurrent low-level troponin I elevation is a worse prognostic indicator than occasional injury pattern in patients hospitalized with heart failure. Int J Cardiol. 2013 Jun 20; 166(2):394-8.
    View in: PubMed
    Score: 0.010
  70. Guiding left ventricular lead positioning and refining ability to predict response and nonresponse to cardiac resynchronization therapy using dP/dt max: killing 3 birds with 1 high-fidelity wire? J Am Coll Cardiol. 2011 Sep 06; 58(11):1137-9.
    View in: PubMed
    Score: 0.009
  71. Association of systolic blood pressure with mortality in patients with heart failure with reduced ejection fraction: a complex relationship. Am Heart J. 2011 Mar; 161(3):567-73.
    View in: PubMed
    Score: 0.009
  72. Where do we currently stand with advice on hormone replacement therapy for women? Methodist Debakey Cardiovasc J. 2010 Nov-2011 Jan; 6(4):21-5.
    View in: PubMed
    Score: 0.009
  73. Biomarkers of inflammation in heart failure. Heart Fail Rev. 2010 Jul; 15(4):331-41.
    View in: PubMed
    Score: 0.009
  74. Digoxin treatment in heart failure--unveiling risk by cluster analysis of DIG data. Int J Cardiol. 2011 Aug 04; 150(3):264-9.
    View in: PubMed
    Score: 0.009
  75. Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus. Am J Cardiol. 2010 Feb 01; 105(3):373-7.
    View in: PubMed
    Score: 0.008
  76. Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol. 2009 Jul 15; 104(2):270-5.
    View in: PubMed
    Score: 0.008
  77. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events. J Card Fail. 2009 May; 15(4):293-9.
    View in: PubMed
    Score: 0.008
  78. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy. Am J Cardiol. 2008 Nov 15; 102(10):1356-60.
    View in: PubMed
    Score: 0.008
  79. 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2026 Jun 09; 87(22S):e1889-e2007.
    View in: PubMed
    Score: 0.007
  80. Ambulatory Stage C2D Heart Failure Definitions and Current Therapeutic Approaches: JACC: Heart Failure Position Statement. JACC Heart Fail. 2026 Jun; 14(6):103101.
    View in: PubMed
    Score: 0.007
  81. Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines. J Am Coll Cardiol. 2026 Apr 21; 87(15):1936-1949.
    View in: PubMed
    Score: 0.006
  82. Kidney disease and heart failure: recent advances and current challenges: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2026 Jun; 109(6):1095-1113.
    View in: PubMed
    Score: 0.006
  83. Kidney Disease and Heart Failure: Recent Advances and Current Challenges: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. JACC Heart Fail. 2026 Apr; 14(4):102943.
    View in: PubMed
    Score: 0.006
  84. Ten years real-world experience with sacubitril/valsartan in patients with heart failure with reduced ejection fraction. ESC Heart Fail. 2026 Mar 03; 13(2).
    View in: PubMed
    Score: 0.006
  85. Comparison of morbidity in women versus men with heart failure and preserved ejection fraction. Am J Cardiol. 2006 Apr 15; 97(8):1228-31.
    View in: PubMed
    Score: 0.006
  86. Integrated Health Technologies in Heart Failure: A Scientific Statement From the Heart Failure Society of America and the American Association of Heart Failure Nurses. J Card Fail. 2026 Mar; 32(3):619-632.
    View in: PubMed
    Score: 0.006
  87. Integrated Health Technologies in Heart Failure: A Scientific Statement From the Heart Failure Society of America and the American Association of Heart Failure Nurses. Heart Lung. 2026 May-Jun; 77:102681.
    View in: PubMed
    Score: 0.006
  88. Subgroups and Special Populations in Heart Failure Clinical Trials: Insights From the HFC-ARC Expert Consensus Panel. JACC Heart Fail. 2026 Apr; 14(4):102775.
    View in: PubMed
    Score: 0.006
  89. Executive Summary of the KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD). Kidney Int. 2026 Jan; 109(1):44-56.
    View in: PubMed
    Score: 0.006
  90. Obesity as a prognostic factor in chronic symptomatic heart failure. Am Heart J. 2005 Dec; 150(6):1233-9.
    View in: PubMed
    Score: 0.006
  91. Pharmacological treatment for patients with obesity and heart failure: Focus on glucagon-like peptide-1 receptor agonists. European Journal of Heart Failure expert consensus document. Eur J Heart Fail. 2025 Nov; 27(11):2465-2479.
    View in: PubMed
    Score: 0.006
  92. Baseline characteristics in the SYNCHRONIZE?-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes. Diabetes Obes Metab. 2026 Feb; 28(2):1490-1498.
    View in: PubMed
    Score: 0.006
  93. Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE?-1). Diabetes Obes Metab. 2026 Jan; 28(1):337-346.
    View in: PubMed
    Score: 0.006
  94. Urinary markers in heart failure?-?types, timing and thresholds. European Journal of Heart Failure expert consensus document. Eur J Heart Fail. 2025 Nov; 27(11):2372-2396.
    View in: PubMed
    Score: 0.006
  95. Prevention of heart failure after acute myocardial infarction. Lancet. 2025 Sep 13; 406(10508):1154-1170.
    View in: PubMed
    Score: 0.006
  96. Management of patients with heart failure at high risk of hyperkalaemia: The CARE-HK in HF registry. Eur J Heart Fail. 2025 Nov; 27(11):2410-2421.
    View in: PubMed
    Score: 0.006
  97. Timing of Cardiac Resynchronization Therapy Following Stable Medical Therapy in Patients With Heart Failure. JACC Heart Fail. 2025 Oct; 13(10):102515.
    View in: PubMed
    Score: 0.006
  98. Clinical management and therapeutic optimization of patients with heart failure with reduced ejection fraction and low blood pressure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2025 Apr; 27(4):707-722.
    View in: PubMed
    Score: 0.006
  99. Assessment of frailty in patients with heart failure: A new Heart Failure Frailty Score developed by Delphi consensus. ESC Heart Fail. 2025 Jun; 12(3):1818-1831.
    View in: PubMed
    Score: 0.006
  100. Revisiting ICD Therapy for Primary Prevention in Patients With Heart?Failure and Reduced Ejection Fraction. JACC Heart Fail. 2025 01; 13(1):1-13.
    View in: PubMed
    Score: 0.006
  101. Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints. J Cardiovasc Magn Reson. 2025; 27(1):101121.
    View in: PubMed
    Score: 0.006
  102. Takotsubo Syndrome: An International Expert Consensus Report on Practical Challenges and Specific Conditions (Part-1: Diagnostic and Therapeutic Challenges) Balkan Med J. 2024 10 31; 41(6):421-441.
    View in: PubMed
    Score: 0.006
  103. Takotsubo Syndrome: An International Expert Consensus Report on Practical Challenges and Specific Conditions (Part-2: Specific Entities, Risk Stratification and Challenges After Recovery) Balkan Med J. 2024 10 31; 41(6):442-457.
    View in: PubMed
    Score: 0.006
  104. Machine learning in the prevention of heart failure. Heart Fail Rev. 2025 Jan; 30(1):117-129.
    View in: PubMed
    Score: 0.006
  105. Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalemia or High Risk of Hyperkalemia: Rationale and Design of the CARE-HK in HF Registry. J Card Fail. 2025 06; 31(6):881-891.
    View in: PubMed
    Score: 0.006
  106. 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures. Circ Cardiovasc Qual Outcomes. 2024 Sep; 17(9):e000132.
    View in: PubMed
    Score: 0.006
  107. 2024 Update to the 2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American Heart Association/American College of Cardiology Joint Committee on Performance Measures. J Am Coll Cardiol. 2024 Sep 17; 84(12):1123-1143.
    View in: PubMed
    Score: 0.006
  108. 2024 ACC Expert Consensus Decision Pathway on Clinical Assessment, Management, and Trajectory of Patients Hospitalized With Heart?Failure Focused Update: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024 Sep 24; 84(13):1241-1267.
    View in: PubMed
    Score: 0.006
  109. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases. Metabolism. 2024 10; 159:155931.
    View in: PubMed
    Score: 0.006
  110. Patient-Centered Adult Cardiovascular Care: A Scientific Statement From the American Heart Association. Circulation. 2024 May 14; 149(20):e1176-e1188.
    View in: PubMed
    Score: 0.006
  111. Artificial intelligence predictive analytics in heart failure: results of the pilot phase of a pragmatic randomized clinical trial. J Am Med Inform Assoc. 2024 04 03; 31(4):919-928.
    View in: PubMed
    Score: 0.006
  112. Contemporary American and?European?Guidelines for Heart Failure Management: JACC: Heart?Failure Guideline Comparison. JACC Heart Fail. 2024 May; 12(5):810-825.
    View in: PubMed
    Score: 0.006
  113. Cardiovascular toxicity with highly active antiretroviral therapy: review of clinical studies. Cardiovasc Toxicol. 2004; 4(3):243-60.
    View in: PubMed
    Score: 0.006
  114. Left Ventricular Ejection Fraction and the Future of Heart?Failure Phenotyping. JACC Heart Fail. 2024 Mar; 12(3):451-460.
    View in: PubMed
    Score: 0.006
  115. Standardized Definitions for Evaluation of?Acute Decompensated Heart?Failure?Therapies: HF-ARC Expert Panel Paper. JACC Heart Fail. 2024 01; 12(1):1-15.
    View in: PubMed
    Score: 0.006
  116. Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies. Eur J Heart Fail. 2023 12; 25(12):2144-2163.
    View in: PubMed
    Score: 0.006
  117. Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC. Eur J Heart Fail. 2023 11; 25(11):1891-1898.
    View in: PubMed
    Score: 0.005
  118. State-of-the-art document on optimal contemporary management of cardiomyopathies. Eur J Heart Fail. 2023 11; 25(11):1899-1922.
    View in: PubMed
    Score: 0.005
  119. A scoping review of heart failure transitional care quality indicators and outcomes for use in clinical care and research. Eur J Heart Fail. 2023 10; 25(10):1842-1848.
    View in: PubMed
    Score: 0.005
  120. Cardiology patient page. Shortness of breath. Circulation. 2003 Jul 15; 108(2):e11-3.
    View in: PubMed
    Score: 0.005
  121. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease: Insights From the Department of Veterans Affairs. JACC Heart Fail. 2023 08; 11(8 Pt 1):933-942.
    View in: PubMed
    Score: 0.005
  122. Management of Heart Failure-Related Cardiogenic Shock: Practical Guidance for Clinicians. JACC Heart Fail. 2023 07; 11(7):845-851.
    View in: PubMed
    Score: 0.005
  123. Optimizing outcomes in heart failure: 2022 and beyond. ESC Heart Fail. 2023 08; 10(4):2159-2169.
    View in: PubMed
    Score: 0.005
  124. JACC Journals' Pathway Forward With?AI Tools: The Future Is Now. JACC Cardiovasc Interv. 2023 04 10; 16(7):881-883.
    View in: PubMed
    Score: 0.005
  125. JACC Journals' Pathway Forward With?AI Tools: The Future Is Now. J Am Coll Cardiol. 2023 04 18; 81(15):1543-1545.
    View in: PubMed
    Score: 0.005
  126. JACC Journals' Pathway Forward With?AI Tools: The Future Is Now. JACC Clin Electrophysiol. 2023 04; 9(4):607-609.
    View in: PubMed
    Score: 0.005
  127. Use of biomarkers in the management of heart failure: are we there yet? Circulation. 2003 Mar 11; 107(9):1231-3.
    View in: PubMed
    Score: 0.005
  128. Association of Long-term Change in N-Terminal Pro-B-Type Natriuretic Peptide With Incident Heart Failure and Death. JAMA Cardiol. 2023 03 01; 8(3):222-230.
    View in: PubMed
    Score: 0.005
  129. Misconceptions and Facts about Heart Failure with Reduced Ejection Fraction. Am J Med. 2023 05; 136(5):422-431.
    View in: PubMed
    Score: 0.005
  130. Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study. JACC Heart Fail. 2023 04; 11(4):440-450.
    View in: PubMed
    Score: 0.005
  131. Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol. 2003 Jan 15; 41(2):211-4.
    View in: PubMed
    Score: 0.005
  132. Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2023 01 10; 147(2):e4-e30.
    View in: PubMed
    Score: 0.005
  133. NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity? Semin Liver Dis. 2022 11; 42(4):465-474.
    View in: PubMed
    Score: 0.005
  134. Preclinical and clinical assessment of the safety and potential efficacy of thalidomide in heart failure. J Card Fail. 2002 Oct; 8(5):306-14.
    View in: PubMed
    Score: 0.005
  135. Design of the remede System Therapy (reST) study: A prospective non-randomized post-market study collecting clinical data on safety and effectiveness of the remede system for the treatment of central sleep apnea. Sleep Med. 2022 12; 100:238-243.
    View in: PubMed
    Score: 0.005
  136. Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidence. Diabetes Obes Metab. 2022 11; 24(11):2071-2080.
    View in: PubMed
    Score: 0.005
  137. How can we optimise health technology assessment and reimbursement decisions to accelerate access to new cardiovascular medicines? Int J Cardiol. 2022 10 15; 365:61-68.
    View in: PubMed
    Score: 0.005
  138. 2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol. 2022 07 26; 80(4):388-465.
    View in: PubMed
    Score: 0.005
  139. Outcomes of Hospitalizations With Septic Shock Complicated by Types 1 and 2 Myocardial Infarction. Am J Cardiol. 2022 07 01; 174:27-33.
    View in: PubMed
    Score: 0.005
  140. Outcomes and Resource Utilization in Patients Hospitalized with Gastrointestinal Bleeding Complicated by Types 1 and 2 Myocardial Infarction. Am J Med. 2022 08; 135(8):975-983.e2.
    View in: PubMed
    Score: 0.005
  141. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 05 03; 145(18):e895-e1032.
    View in: PubMed
    Score: 0.005
  142. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022 05 03; 145(18):e876-e894.
    View in: PubMed
    Score: 0.005
  143. 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary. J Card Fail. 2022 05; 28(5):810-830.
    View in: PubMed
    Score: 0.005
  144. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 05 03; 79(17):e263-e421.
    View in: PubMed
    Score: 0.005
  145. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022 05 03; 79(17):1757-1780.
    View in: PubMed
    Score: 0.005
  146. An Updated Review on the Role of Non-dihydropyridine Calcium Channel Blockers and Beta-blockers in Atrial Fibrillation and Acute Decompensated Heart Failure: Evidence and Gaps. Cardiovasc Drugs Ther. 2023 12; 37(6):1205-1223.
    View in: PubMed
    Score: 0.005
  147. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022 05 03; 79(17):1717-1756.
    View in: PubMed
    Score: 0.005
  148. The year in cardiovascular medicine 2021: heart failure and cardiomyopathies. Eur Heart J. 2022 Feb 03; 43(5):367-376.
    View in: PubMed
    Score: 0.005
  149. Women leaders: transforming the culture in cardiology. Open Heart. 2022 02; 9(1).
    View in: PubMed
    Score: 0.005
  150. DCRM Multispecialty Practice Recommendations for the management of diabetes, cardiorenal, and metabolic diseases. J Diabetes Complications. 2022 02; 36(2):108101.
    View in: PubMed
    Score: 0.005
  151. Sex Differences in Heart Failure. J Card Fail. 2022 03; 28(3):477-498.
    View in: PubMed
    Score: 0.005
  152. Cardiac rehabilitation in heart failure: Indications for exercise training based on heart failure phenotype. Prog Cardiovasc Dis. 2022 Jan-Feb; 70:16-21.
    View in: PubMed
    Score: 0.005
  153. Public perception of heart failure on twitter: A sentiment analysis. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:91-93.
    View in: PubMed
    Score: 0.005
  154. Proinflammatory TH17 cytokine activation, disease severity and outcomes in peripartum cardiomyopathy. Int J Cardiol. 2021 Sep 15; 339:93-98.
    View in: PubMed
    Score: 0.005
  155. Patient Characteristics and Outcomes of Type 2 Myocardial Infarction During Heart Failure Hospitalizations in the United States. Am J Med. 2021 11; 134(11):1371-1379.e2.
    View in: PubMed
    Score: 0.005
  156. Obstructive Sleep Apnea and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2021 07 20; 144(3):e56-e67.
    View in: PubMed
    Score: 0.005
  157. Ending Gender Inequality in Cardiovascular Clinical Trial Leadership: JACC Review Topic of the Week. J Am Coll Cardiol. 2021 06 15; 77(23):2960-2972.
    View in: PubMed
    Score: 0.005
  158. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. Eur J Heart Fail. 2021 06; 23(6):854-871.
    View in: PubMed
    Score: 0.005
  159. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy. J Card Fail. 2021 07; 27(7):727-743.
    View in: PubMed
    Score: 0.005
  160. 2021: The American Association for Thoracic Surgery Expert Consensus Document: Coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure. J Thorac Cardiovasc Surg. 2021 Sep; 162(3):829-850.e1.
    View in: PubMed
    Score: 0.005
  161. The role of anti-cytokine therapy in the failing heart. Heart Fail Rev. 2001 Mar; 6(2):143-51.
    View in: PubMed
    Score: 0.005
  162. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation. 2001 Feb 27; 103(8):1044-7.
    View in: PubMed
    Score: 0.005
  163. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571.
    View in: PubMed
    Score: 0.005
  164. Activation of cytokines as a mechanism of disease progression in heart failure. Ann Rheum Dis. 2000 Nov; 59 Suppl 1:i90-3.
    View in: PubMed
    Score: 0.004
  165. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nat Rev Cardiol. 2021 03; 18(3):169-193.
    View in: PubMed
    Score: 0.004
  166. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices. Hypertension. 2020 11; 76(5):1350-1367.
    View in: PubMed
    Score: 0.004
  167. Impact of the SARS-CoV-2 pandemic on health-care workers. Hosp Pract (1995). 2020 Oct; 48(4):161-164.
    View in: PubMed
    Score: 0.004
  168. Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC). Eur Heart J. 2020 06 07; 41(22):2109-2117.
    View in: PubMed
    Score: 0.004
  169. Cardiac Surgery During the Coronavirus Disease 2019 Pandemic: Perioperative Considerations and Triage Recommendations. J Am Heart Assoc. 2020 07 07; 9(13):e017042.
    View in: PubMed
    Score: 0.004
  170. Age-Stratified Sex Disparities in Care and Outcomes in Patients With ST-Elevation Myocardial Infarction. Am J Med. 2020 11; 133(11):1293-1301.e1.
    View in: PubMed
    Score: 0.004
  171. Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome. Circulation. 2020 06 09; 141(23):1903-1914.
    View in: PubMed
    Score: 0.004
  172. Endpoints in Heart?Failure Drug?Development: History and Future. JACC Heart Fail. 2020 06; 8(6):429-440.
    View in: PubMed
    Score: 0.004
  173. Evaluation for Heart Transplantation and?LVAD Implantation: JACC Council Perspectives. J Am Coll Cardiol. 2020 03 31; 75(12):1471-1487.
    View in: PubMed
    Score: 0.004
  174. Continuous Wearable Monitoring Analytics Predict Heart Failure Hospitalization: The LINK-HF Multicenter Study. Circ Heart Fail. 2020 03; 13(3):e006513.
    View in: PubMed
    Score: 0.004
  175. 2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart?Failure: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2019 10 15; 74(15):1966-2011.
    View in: PubMed
    Score: 0.004
  176. Intravenous immune globulin in the therapy of peripartum cardiomyopathy. J Am Coll Cardiol. 1999 Jul; 34(1):177-80.
    View in: PubMed
    Score: 0.004
  177. Impact of a Resident-Centered Interprofessional Quality Improvement Intervention on Acute Care Length of Stay. J Healthc Qual. 2019 Jul/Aug; 41(4):212-219.
    View in: PubMed
    Score: 0.004
  178. 2019 ACC/AHA/ASE Key Data Elements and Definitions for Transthoracic Echocardiography: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Transthoracic Echocardiography) and the American Society of Echocardiography. J Am Soc Echocardiogr. 2019 09; 32(9):1161-1248.
    View in: PubMed
    Score: 0.004
  179. Medical and surgical therapy for cardiac remodeling. Curr Opin Cardiol. 1999 May; 14(3):196-205.
    View in: PubMed
    Score: 0.004
  180. Heart Failure Site-Based Research in?the United States: Results of the Heart Failure Society of America Research?Network Survey. JACC Heart Fail. 2019 05; 7(5):431-438.
    View in: PubMed
    Score: 0.004
  181. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 04 02; 139(14):e698-e800.
    View in: PubMed
    Score: 0.004
  182. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 04 02; 139(14):e637-e697.
    View in: PubMed
    Score: 0.004
  183. Venoarterial ECMO for Adults: JACC Scientific Expert Panel. J Am Coll Cardiol. 2019 02 19; 73(6):698-716.
    View in: PubMed
    Score: 0.004
  184. Lifestyle Modifications for Preventing?and Treating Heart?Failure. J Am Coll Cardiol. 2018 11 06; 72(19):2391-2405.
    View in: PubMed
    Score: 0.004
  185. Maternal Obesity Affects Cardiac Remodeling and Recovery in Women with Peripartum Cardiomyopathy. Am J Perinatol. 2019 04; 36(5):476-483.
    View in: PubMed
    Score: 0.004
  186. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 04 02; 73(12):e81-e192.
    View in: PubMed
    Score: 0.004
  187. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive?Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019 04 02; 73(12):1494-1563.
    View in: PubMed
    Score: 0.004
  188. American Heart Association Diabetes and Cardiometabolic Health Summit: Summary and Recommendations. J Am Heart Assoc. 2018 08 07; 7(15):e009271.
    View in: PubMed
    Score: 0.004
  189. The 2017 AHA/ACC Performance and Quality Measures for Patients With Acute Myocardial Infarction. JAMA Cardiol. 2018 07 01; 3(7):659-660.
    View in: PubMed
    Score: 0.004
  190. Ticagrelor Use in Acute Myocardial Infarction: Insights From the National Cardiovascular Data Registry. J Am Heart Assoc. 2018 06 09; 7(12).
    View in: PubMed
    Score: 0.004
  191. Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2018 05 15; 137(20):e578-e622.
    View in: PubMed
    Score: 0.004
  192. Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study. J Card Fail. 2018 01; 24(1):33-42.
    View in: PubMed
    Score: 0.004
  193. 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary. Vasc Med. 2017 06; 22(3):NP1-NP43.
    View in: PubMed
    Score: 0.004
  194. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2017 08 08; 136(6):e137-e161.
    View in: PubMed
    Score: 0.004
  195. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the?Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017 08 08; 70(6):776-803.
    View in: PubMed
    Score: 0.004
  196. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the?Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Card Fail. 2017 08; 23(8):628-651.
    View in: PubMed
    Score: 0.004
  197. Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2017 May 30; 135(22):e1054-e1091.
    View in: PubMed
    Score: 0.004
  198. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
    View in: PubMed
    Score: 0.003
  199. Myocardial Injury, Obesity, and the Obesity Paradox: The ARIC Study. JACC Heart Fail. 2017 01; 5(1):56-63.
    View in: PubMed
    Score: 0.003
  200. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study. Eur J Prev Cardiol. 2017 04; 24(6):628-638.
    View in: PubMed
    Score: 0.003
  201. 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg. 2016 11; 152(5):1243-1275.
    View in: PubMed
    Score: 0.003
  202. Temporal Trends in Care and Outcomes of Patients Receiving Fibrinolytic Therapy Compared to Primary Percutaneous Coronary Intervention: Insights From the Get With The Guidelines Coronary Artery Disease (GWTG-CAD) Registry. J Am Heart Assoc. 2016 10 06; 5(10).
    View in: PubMed
    Score: 0.003
  203. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation. 2016 09 27; 134(13):e282-93.
    View in: PubMed
    Score: 0.003
  204. 2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task?Force?on?Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2016 09 27; 68(13):1476-1488.
    View in: PubMed
    Score: 0.003
  205. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial Infarction: An update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv. 2016 May; 87(6):1001-19.
    View in: PubMed
    Score: 0.003
  206. Relaxin-2 and Soluble Flt1 Levels in Peripartum Cardiomyopathy: Results of the Multicenter IPAC Study. JACC Heart Fail. 2016 05; 4(5):380-8.
    View in: PubMed
    Score: 0.003
  207. Surgery for Aortic Dilatation in Patients With Bicuspid Aortic Valves: A Statement of Clarification From the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016 Feb 16; 133(7):680-6.
    View in: PubMed
    Score: 0.003
  208. Diagnosis and management of acute heart failure. Anatol J Cardiol. 2015 Nov; 15(11):860-89.
    View in: PubMed
    Score: 0.003
  209. Provider Type and Quality of Outpatient Cardiovascular Disease Care: Insights From the NCDR PINNACLE Registry. J Am Coll Cardiol. 2015 Oct 20; 66(16):1803-1812.
    View in: PubMed
    Score: 0.003
  210. Severity of hypoxia modulates effect of CPAP on myocardial stress as measured by highly sensitive troponin T. Respir Res. 2015 Oct 16; 16:126.
    View in: PubMed
    Score: 0.003
  211. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Nucl Cardiol. 2015 Oct; 22(5):1041-144.
    View in: PubMed
    Score: 0.003
  212. Further Evolution of the ACC/AHA Clinical Practice Guideline Recommendation Classification System: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2016 04 05; 67(13):1572-1574.
    View in: PubMed
    Score: 0.003
  213. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Developed in collaboration with the American College of Surgeons, American Society of Anesthesiologists, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Anesthesiologists, and Society of Vascular Medicine Endorsed by the Society of Hospital Medicine. J Nucl Cardiol. 2015 Feb; 22(1):162-215.
    View in: PubMed
    Score: 0.003
  214. Pre-morbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol. 2014 Dec 30; 64(25):2743-9.
    View in: PubMed
    Score: 0.003
  215. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). Circulation. 2015 Jul 28; 132(4):302-61.
    View in: PubMed
    Score: 0.003
  216. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards). J Am Coll Cardiol. 2015 Jul 28; 66(4):403-69.
    View in: PubMed
    Score: 0.003
  217. 2014 ACC/AHA/AATS/PCNA/SCAI/STS focused update of the guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, and the American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):e5-23.
    View in: PubMed
    Score: 0.003
  218. High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study. Hypertension. 2015 Jan; 65(1):78-84.
    View in: PubMed
    Score: 0.003
  219. Gender disparities in evidence-based statin therapy in patients with cardiovascular disease. Am J Cardiol. 2015 Jan 01; 115(1):21-6.
    View in: PubMed
    Score: 0.003
  220. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Circulation. 2014 Sep 30; 130(14):1208-17.
    View in: PubMed
    Score: 0.003
  221. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 09; 130(24):e278-333.
    View in: PubMed
    Score: 0.003
  222. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 09; 130(24):2215-45.
    View in: PubMed
    Score: 0.003
  223. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2014 Dec 09; 64(22):e77-137.
    View in: PubMed
    Score: 0.003
  224. Circulating collagen biomarkers as indicators of disease severity in pulmonary arterial hypertension. JACC Heart Fail. 2014 Aug; 2(4):412-21.
    View in: PubMed
    Score: 0.003
  225. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):e1-e132.
    View in: PubMed
    Score: 0.003
  226. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014 Jun 01; 113(11):1834-8.
    View in: PubMed
    Score: 0.003
  227. Revascularization improves mortality in elderly patients with acute myocardial infarction complicated by cardiogenic shock. Int J Cardiol. 2014 Mar 01; 172(1):239-41.
    View in: PubMed
    Score: 0.003
  228. Early experience of a transcatheter aortic valve program at a Veterans Affairs facility. JAMA Surg. 2013 Dec; 148(12):1087-93.
    View in: PubMed
    Score: 0.003
  229. ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. Circulation. 2014 Jun 03; 129(22):2346-57.
    View in: PubMed
    Score: 0.003
  230. ACC/AHA 2013 methodology for developing clinical data standards: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol. 2014 Jun 03; 63(21):2323-34.
    View in: PubMed
    Score: 0.003
  231. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24; 129(25 Suppl 2):S76-99.
    View in: PubMed
    Score: 0.003
  232. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24; 129(25 Suppl 2):S1-45.
    View in: PubMed
    Score: 0.003
  233. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24; 129(25 Suppl 2):S102-38.
    View in: PubMed
    Score: 0.003
  234. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Jun 24; 129(25 Suppl 2):S49-73.
    View in: PubMed
    Score: 0.003
  235. Patients with severe chronic kidney disease benefit from early revascularization after acute coronary syndrome. Int J Cardiol. 2013 Oct 09; 168(4):3741-6.
    View in: PubMed
    Score: 0.003
  236. Cardiovascular function and treatment in ?-thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013 Jul 16; 128(3):281-308.
    View in: PubMed
    Score: 0.003
  237. 2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; 128(16):1810-52.
    View in: PubMed
    Score: 0.003
  238. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation. 2013 Oct 15; 128(16):e240-327.
    View in: PubMed
    Score: 0.003
  239. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 Oct 15; 62(16):e147-239.
    View in: PubMed
    Score: 0.003
  240. Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013 May 07; 61(18):1935-44.
    View in: PubMed
    Score: 0.003
  241. Transcatheter aortic valve replacement as a treatment for late apicoaortic conduit obstruction in a patient with severe aortic stenosis. Circulation. 2013 Mar 19; 127(11):e491-4.
    View in: PubMed
    Score: 0.003
  242. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Apr 02; 127(13):1425-43.
    View in: PubMed
    Score: 0.003
  243. Percutaneous coronary intervention vs. coronary artery bypass graft surgery for unprotected left main coronary artery disease in the drug-eluting stents era--an aggregate data meta-analysis of 11,148 patients. Circ J. 2013; 77(2):372-82.
    View in: PubMed
    Score: 0.003
  244. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012 Oct 16; 60(16):1581-98.
    View in: PubMed
    Score: 0.003
  245. Establishment of a transcatheter aortic valve program and heart valve team at a Veterans Affairs facility. Am J Surg. 2012 Nov; 204(5):643-8.
    View in: PubMed
    Score: 0.003
  246. Prevalence, morbidity, and mortality of heart failure-related hospitalizations in children in the United States: a population-based study. J Card Fail. 2012 Jun; 18(6):459-70.
    View in: PubMed
    Score: 0.002
  247. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012 Mar 13; 59(11):998-1005.
    View in: PubMed
    Score: 0.002
  248. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012 Feb 28; 125(8):1058-72.
    View in: PubMed
    Score: 0.002
  249. Programmable bio-nanochip technology for the diagnosis of cardiovascular disease at the point-of-care. Methodist Debakey Cardiovasc J. 2012 Jan; 8(1):6-12.
    View in: PubMed
    Score: 0.002
  250. 2012 ACCF/AHA/ACR/SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease). Circulation. 2012 Jan 17; 125(2):395-467.
    View in: PubMed
    Score: 0.002
  251. Barriers to non-HDL cholesterol goal attainment by providers. Am J Med. 2011 Sep; 124(9):876-80.e2.
    View in: PubMed
    Score: 0.002
  252. ACCF/AHA 2011 key data elements and definitions of a base cardiovascular vocabulary for electronic health records: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards. Circulation. 2011 Jul 05; 124(1):103-23.
    View in: PubMed
    Score: 0.002
  253. Results of the Randomized Aldosterone Antagonism in Heart Failure with Preserved Ejection Fraction trial (RAAM-PEF). J Card Fail. 2011 Aug; 17(8):634-42.
    View in: PubMed
    Score: 0.002
  254. Central venous pressure and pulmonary capillary wedge pressure: fresh clinical perspectives from a new model of discordant and concordant heart failure. Tex Heart Inst J. 2011; 38(6):627-38.
    View in: PubMed
    Score: 0.002
  255. Trials on the effect of cardiac resynchronization on arterial blood pressure in patients with heart failure. Am J Cardiol. 2011 Feb 15; 107(4):561-8.
    View in: PubMed
    Score: 0.002
  256. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail. 2011 Jan; 4(1):53-8.
    View in: PubMed
    Score: 0.002
  257. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol. 2009 Jul 28; 54(5):422-8.
    View in: PubMed
    Score: 0.002
  258. Acute bacterial pneumonia is associated with the occurrence of acute coronary syndromes. Medicine (Baltimore). 2009 May; 88(3):154-159.
    View in: PubMed
    Score: 0.002
  259. Does the level of experience of residents affect outcomes of coronary artery bypass surgery? Ann Thorac Surg. 2009 Apr; 87(4):1127-33; discussion 1133-4.
    View in: PubMed
    Score: 0.002
  260. The association between Staphylococcus aureus bacteremia and acute myocardial infarction. Scand J Infect Dis. 2009; 41(6-7):511-4.
    View in: PubMed
    Score: 0.002
  261. Sex differences in medical care and early death after acute myocardial infarction. Circulation. 2008 Dec 16; 118(25):2803-10.
    View in: PubMed
    Score: 0.002
  262. The July effect and cardiac surgery: the effect of the beginning of the academic cycle on outcomes. Am J Surg. 2008 Nov; 196(5):720-5.
    View in: PubMed
    Score: 0.002
  263. Does the use of bilateral internal mammary artery grafts impact survival of veterans undergoing coronary artery bypass surgery? Am J Surg. 2008 Nov; 196(5):726-31.
    View in: PubMed
    Score: 0.002
  264. Effect of the soluble TNF-antagonist etanercept on tumor necrosis factor bioactivity and stability. Clin Transl Sci. 2008 Sep; 1(2):142-5.
    View in: PubMed
    Score: 0.002
  265. The metabolic syndrome and mortality in an ethnically diverse heart failure population. J Card Fail. 2008 Sep; 14(7):590-5.
    View in: PubMed
    Score: 0.002
  266. The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. J Am Coll Cardiol. 2007 Jul 03; 50(1):32-6.
    View in: PubMed
    Score: 0.002
  267. Effect of atrial overdrive pacing on obstructive sleep apnea in patients with systolic heart failure. Sleep Med. 2007 Jan; 8(1):31-6.
    View in: PubMed
    Score: 0.002
  268. Plasma matrix metalloproteinase and inhibitor profiles in patients with heart failure. J Card Fail. 2002 Dec; 8(6):390-8.
    View in: PubMed
    Score: 0.001
  269. End-stage cardiac failure in a morbidly obese patient treated by biliopancreatic diversion and cardiac transplantation. Obes Surg. 2002 Jun; 12(3):416-8.
    View in: PubMed
    Score: 0.001
  270. Tumor necrosis factor-alpha and myocardial remodeling in progression of heart failure: a current perspective. Cardiovasc Res. 2002 Mar; 53(4):822-30.
    View in: PubMed
    Score: 0.001
  271. New therapeutics for chronic heart failure. Annu Rev Med. 2002; 53:59-74.
    View in: PubMed
    Score: 0.001
  272. Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure. Circulation. 2001 Feb 20; 103(7):973-80.
    View in: PubMed
    Score: 0.001
  273. Experimental options in the treatment of heart failure: the role of cytokine antagonism. Heart Fail Monit. 2001; 1(4):114-21.
    View in: PubMed
    Score: 0.001
  274. Veterans Affairs Quality Enhancement Research Initiative in chronic heart failure. Med Care. 2000 Jun; 38(6 Suppl 1):I26-37.
    View in: PubMed
    Score: 0.001
  275. Cytokines in heart failure: pathogenetic mechanisms and potential treatment. Proc Assoc Am Physicians. 1999 Sep-Oct; 111(5):423-8.
    View in: PubMed
    Score: 0.001
  276. Safety and efficacy of a soluble P75 tumor necrosis factor receptor (Enbrel, etanercept) in patients with advanced heart failure. Circulation. 1999 Jun 29; 99(25):3224-6.
    View in: PubMed
    Score: 0.001
  277. An overview of tumor necrosis factor alpha and the failing human heart. Curr Opin Cardiol. 1999 May; 14(3):206-10.
    View in: PubMed
    Score: 0.001
  278. Cardiac remodeling as a consequence and cause of progressive heart failure. Clin Cardiol. 1998 Dec; 21(12 Suppl 1):I14-9.
    View in: PubMed
    Score: 0.001
  279. The role of cytokines in the failing human heart. Cardiol Clin. 1998 Nov; 16(4):645-56, viii.
    View in: PubMed
    Score: 0.001
  280. Progressive dehiscence and dynamic compression of an aortic root homograft: detection and characterization by transesophageal echocardiography. Am Heart J. 1996 Nov; 132(5):1070-3.
    View in: PubMed
    Score: 0.001
  281. Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail. 1996 Sep; 2(3):243-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.